All Cancercare Connect Education Workshops

Updates in the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 46th Annual San Antonio Breast Cancer Symposium (SABCS)

Informações:

Sinopse

- Updates from the 46th SABCS on Diagnostic Testing, Biomarkers, Precision Medicine, Grade & Hormone Receptors - What’s New in the Treatment of ER, PR and HER2 Positive Breast Cancer - Updates from SABCS on: Hormone & Targeted Therapy - Chemotherapy Updates from SABCS - Investigational New Drugs in Clinical Trials - What’s New in Prevention & Management of Treatment Side Effects, Discomfort, Neuropathy & Long Term Effects - Questions to Ask Your Health Care Team - Questions for Our Panel of Experts